These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22990329)

  • 1. Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention.
    Garcia BH; Småbrekke L; Trovik T; Giverhaug T
    Eur J Clin Pharmacol; 2013 Mar; 69(3):703-9. PubMed ID: 22990329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.
    Ergatoudes C; Thunström E; Rosengren A; Björck L; Bengtsson Boström K; Falk K; Fu M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):226. PubMed ID: 27855640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAT-CHDSP, a novel medication assessment tool for evaluation of secondary prevention of coronary heart disease.
    Garcia BH; Utnes J; Naalsund LU; Giverhaug T
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):249-57. PubMed ID: 21351306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.
    Pedersen E; Garcia BH; Halvorsen KH; Eggen AE; Schirmer H; Waaseth M
    BMC Cardiovasc Disord; 2021 Jan; 21(1):44. PubMed ID: 33478404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental Prognostic Value of Guideline-Directed Medical Therapy, Transradial Access, and Door-to-Balloon Time on Outcomes in ST-Segment-Elevation Myocardial Infarction.
    Huded CP; Kumar A; Johnson M; Abdallah M; Ballout JA; Kravitz K; Menon V; Gullett TC; Hantz S; Ellis SG; Podolsky SR; Meldon SW; Kralovic DM; Brosovich D; Smith E; Kapadia SR; Khot UN
    Circ Cardiovasc Interv; 2019 Mar; 12(3):e007101. PubMed ID: 30871354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines.
    Stark R; Kirchberger I; Hunger M; Heier M; Leidl R; von Scheidt W; Meisinger C; Holle R
    Clin Res Cardiol; 2014 Mar; 103(3):237-45. PubMed ID: 24287605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAT-CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community-acquired pneumonia.
    Høgli JU; Småbrekke L; Garcia BH
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):933-41. PubMed ID: 24797586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
    Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
    Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease.
    Jortveit J; Halvorsen S; Kaldal A; Pripp AH; Govatsmark RES; Langørgen J
    BMC Cardiovasc Disord; 2019 Mar; 19(1):71. PubMed ID: 30922234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus.
    Kamyar M; Johnson BJ; McAnaw JJ; Lemmens-Gruber R; Hudson SA
    Pharm World Sci; 2008 Jan; 30(1):120-7. PubMed ID: 17721698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
    Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of optimal medical therapy in patients undergoing percutaneous coronary intervention for acute coronary syndrome in octogenarians.
    Anzai A; Maekawa Y; Kodaira M; Mogi S; Arai T; Kawakami T; Kanazawa H; Hayashida K; Yuasa S; Kawamura A; Fukuda K
    Heart Vessels; 2015 Mar; 30(2):186-92. PubMed ID: 24493327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
    Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS
    Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention in coronary heart disease: goal achievement and drug prescribing.
    Giverhaug T; Bruland C; Trovik T
    Pharm World Sci; 2005 Dec; 27(6):472-4. PubMed ID: 16341957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings.
    Hannan EL; Samadashvili Z; Cozzens K; Berger PB; Chikwe J; Jacobs AK; Walford G; Ling FSK; Venditti FJ; Gold J; King SB
    JACC Cardiovasc Interv; 2018 Mar; 11(5):473-478. PubMed ID: 29519380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assessment of peripheral artery disease clinical guidelines.
    Barriocanal AM; López A; Monreal M; Montané E
    J Vasc Surg; 2016 Apr; 63(4):1091-8. PubMed ID: 27016858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacist-led follow-up program for patients with established coronary heart disease in North Norway - a randomized controlled trial.
    Garcia BH; Giverhaug T; Høgli JU; Skjold F; Småbrekke L
    Pharm Pract (Granada); 2015; 13(2):575. PubMed ID: 26131047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.